Pharmaceutical compositions comprising thiram

   
   

Thiram (tetramethyliuram disulfide) is shown to inhibit angiogenesis and/or inflammation and to be useful in the treatment of angiogenesis-dependent disorders, including neoplasms, and in the inhibition, treatment and allevation of inflammation associated with several disorders and diseases, such as rheumatoid arthritis. Thiram is further useful for prevention of cell hyperproliferation and formation of clots along or around medical devices.

 
Web www.patentalert.com

< Methods for detecting lesions in dense breast tissue using LHRH antagonists

< Meta-benzamidine derivatives as serine protease inhibitors

> Method of treatment of cardiovascular injuries

> Ubiquitin ligase assay

~ 00113